title: [Spondyloarthritis - the novel concept. An introduction to the diagnosis and treatment of axial spondyloarthritis].
abstract: The characteristic features of spondyloarthritis are inflammation in the axial skeleton (sacroiliitis, spondylitis) and inflammation in peripheral joints (arthritis) and entheses (enthesitis). According to the leading clinical symptom SpA is today differentiated in the either predominant axial or the peripheral form. The axial SpA are further subdivided in ankylosing spondylitis and non-radiographic axial SpA. This subset is characterized by the absence of structural changes on conventional x-rays. In this review we describe the clinical symptoms, the diagnosis and therapy of patients with axial SpA.
authors.affiliation: Rheumazentrum Ruhrgebiet, Herne. kiltz@rheumazentrumruhrgebiet.de
authors.forename: U
authors.initials: U
authors.lastname: Kiltz
authors.forename: X
authors.initials: X
authors.lastname: Baraliakos
authors.forename: J
authors.initials: J
authors.lastname: Braun
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003937:Diagnosis, Differential; D018450:Disease Progression; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D008297:Male; D026741:Physical Therapy Modalities; D012307:Risk Factors; D025242:Spondylarthropathies / Q000145:classification / Q000175:diagnosis* / Q000628:therapy*; D013167:Spondylitis, Ankylosing / Q000145:classification / Q000175:diagnosis* / Q000628:therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D014409:Tumor Necrosis Factor-alpha